XML 77 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Sales by segment of business    
Sales to customers $ 21,383 $ 20,894
Percent Change (as a percent) 2.30%  
U.S.    
Sales by segment of business    
Sales to customers $ 11,620 10,782
Percent Change (as a percent) 7.80%  
International    
Sales by segment of business    
Sales to customers $ 9,763 10,112
Percent Change (as a percent) (3.40%)  
MEDTECH    
Sales by segment of business    
Sales to customers $ 7,821 7,481
Percent Change (as a percent) 4.50%  
MEDTECH | U.S.    
Sales by segment of business    
Sales to customers $ 4,008 3,759
Percent Change (as a percent) 6.60%  
MEDTECH | International    
Sales by segment of business    
Sales to customers $ 3,813 3,722
Percent Change (as a percent) 2.40%  
MEDTECH | Cardiovascular(2)    
Sales by segment of business    
Sales to customers $ 1,806 1,503
Percent Change (as a percent) 20.20%  
MEDTECH | Cardiovascular(2) | U.S.    
Sales by segment of business    
Sales to customers $ 1,025 863
Percent Change (as a percent) 18.80%  
MEDTECH | Cardiovascular(2) | International    
Sales by segment of business    
Sales to customers $ 781 640
Percent Change (as a percent) 22.10%  
MEDTECH | ELECTROPHYSIOLOGY    
Sales by segment of business    
Sales to customers $ 1,344 1,092
Percent Change (as a percent) 23.00%  
MEDTECH | ELECTROPHYSIOLOGY | U.S.    
Sales by segment of business    
Sales to customers $ 692 571
Percent Change (as a percent) 21.30%  
MEDTECH | ELECTROPHYSIOLOGY | International    
Sales by segment of business    
Sales to customers $ 652 522
Percent Change (as a percent) 24.90%  
MEDTECH | ABIOMED    
Sales by segment of business    
Sales to customers $ 371 324
Percent Change (as a percent) 14.50%  
MEDTECH | ABIOMED | U.S.    
Sales by segment of business    
Sales to customers $ 303 264
Percent Change (as a percent) 15.00%  
MEDTECH | ABIOMED | International    
Sales by segment of business    
Sales to customers $ 67 60
Percent Change (as a percent) 12.40%  
MEDTECH | OTHER CARDIOVASCULAR(2)    
Sales by segment of business    
Sales to customers $ 92 87
Percent Change (as a percent) 5.70%  
MEDTECH | OTHER CARDIOVASCULAR(2) | U.S.    
Sales by segment of business    
Sales to customers $ 30 28
Percent Change (as a percent) 3.30%  
MEDTECH | OTHER CARDIOVASCULAR(2) | International    
Sales by segment of business    
Sales to customers $ 62 58
Percent Change (as a percent) 6.90%  
MEDTECH | Orthopaedics    
Sales by segment of business    
Sales to customers $ 2,340 2,245
Percent Change (as a percent) 4.30%  
MEDTECH | Orthopaedics | U.S.    
Sales by segment of business    
Sales to customers $ 1,448 1,363
Percent Change (as a percent) 6.20%  
MEDTECH | Orthopaedics | International    
Sales by segment of business    
Sales to customers $ 892 881
Percent Change (as a percent) 1.30%  
MEDTECH | Orthopaedics | HIPS    
Sales by segment of business    
Sales to customers $ 422 390
Percent Change (as a percent) 8.10%  
MEDTECH | Orthopaedics | HIPS | U.S.    
Sales by segment of business    
Sales to customers $ 270 241
Percent Change (as a percent) 12.10%  
MEDTECH | Orthopaedics | HIPS | International    
Sales by segment of business    
Sales to customers $ 152 149
Percent Change (as a percent) 1.70%  
MEDTECH | Orthopaedics | KNEES    
Sales by segment of business    
Sales to customers $ 401 368
Percent Change (as a percent) 9.00%  
MEDTECH | Orthopaedics | KNEES | U.S.    
Sales by segment of business    
Sales to customers $ 242 226
Percent Change (as a percent) 6.90%  
MEDTECH | Orthopaedics | KNEES | International    
Sales by segment of business    
Sales to customers $ 160 142
Percent Change (as a percent) 12.30%  
MEDTECH | Orthopaedics | TRAUMA    
Sales by segment of business    
Sales to customers $ 765 757
Percent Change (as a percent) 1.00%  
MEDTECH | Orthopaedics | TRAUMA | U.S.    
Sales by segment of business    
Sales to customers $ 504 491
Percent Change (as a percent) 2.80%  
MEDTECH | Orthopaedics | TRAUMA | International    
Sales by segment of business    
Sales to customers $ 261 267
Percent Change (as a percent) (2.30%)  
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER    
Sales by segment of business    
Sales to customers $ 752 729
Percent Change (as a percent) 3.20%  
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | U.S.    
Sales by segment of business    
Sales to customers $ 432 406
Percent Change (as a percent) 6.50%  
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | International    
Sales by segment of business    
Sales to customers $ 320 323
Percent Change (as a percent) (0.90%)  
MEDTECH | Surgery    
Sales by segment of business    
Sales to customers $ 2,416 2,434
Percent Change (as a percent) (0.70%)  
MEDTECH | Surgery | U.S.    
Sales by segment of business    
Sales to customers $ 987 975
Percent Change (as a percent) 1.20%  
MEDTECH | Surgery | International    
Sales by segment of business    
Sales to customers $ 1,429 1,459
Percent Change (as a percent) (2.00%)  
MEDTECH | Surgery | ADVANCED    
Sales by segment of business    
Sales to customers $ 1,087 1,118
Percent Change (as a percent) (2.80%)  
MEDTECH | Surgery | ADVANCED | U.S.    
Sales by segment of business    
Sales to customers $ 446 444
Percent Change (as a percent) 0.20%  
MEDTECH | Surgery | ADVANCED | International    
Sales by segment of business    
Sales to customers $ 641 673
Percent Change (as a percent) (4.70%)  
MEDTECH | Surgery | GENERAL    
Sales by segment of business    
Sales to customers $ 1,330 1,316
Percent Change (as a percent) 1.00%  
MEDTECH | Surgery | GENERAL | U.S.    
Sales by segment of business    
Sales to customers $ 542 531
Percent Change (as a percent) 2.10%  
MEDTECH | Surgery | GENERAL | International    
Sales by segment of business    
Sales to customers $ 788 785
Percent Change (as a percent) 0.30%  
MEDTECH | Vision    
Sales by segment of business    
Sales to customers $ 1,258 1,300
Percent Change (as a percent) (3.30%)  
MEDTECH | Vision | U.S.    
Sales by segment of business    
Sales to customers $ 547 558
Percent Change (as a percent) (1.80%)  
MEDTECH | Vision | International    
Sales by segment of business    
Sales to customers $ 710 743
Percent Change (as a percent) (4.40%)  
MEDTECH | Vision | CONTACT LENSES / OTHER    
Sales by segment of business    
Sales to customers $ 910 953
Percent Change (as a percent) (4.60%)  
MEDTECH | Vision | CONTACT LENSES / OTHER | U.S.    
Sales by segment of business    
Sales to customers $ 438 444
Percent Change (as a percent) (1.40%)  
MEDTECH | Vision | CONTACT LENSES / OTHER | International    
Sales by segment of business    
Sales to customers $ 472 509
Percent Change (as a percent) (7.40%)  
MEDTECH | Vision | SURGICAL    
Sales by segment of business    
Sales to customers $ 348 347
Percent Change (as a percent) 0.30%  
MEDTECH | Vision | SURGICAL | U.S.    
Sales by segment of business    
Sales to customers $ 110 114
Percent Change (as a percent) (3.70%)  
MEDTECH | Vision | SURGICAL | International    
Sales by segment of business    
Sales to customers $ 238 233
Percent Change (as a percent) 2.20%  
Innovative Medicine    
Sales by segment of business    
Sales to customers $ 13,562 13,413
Percent Change (as a percent) 1.10%  
Innovative Medicine | U.S.    
Sales by segment of business    
Sales to customers $ 7,612 7,023
Percent Change (as a percent) 8.40%  
Innovative Medicine | International    
Sales by segment of business    
Sales to customers $ 5,950 6,390
Percent Change (as a percent) (6.90%)  
Innovative Medicine | Immunology    
Sales by segment of business    
Sales to customers $ 4,247 4,112
Percent Change (as a percent) 3.30%  
Innovative Medicine | Immunology | U.S.    
Sales by segment of business    
Sales to customers $ 2,453 2,448
Percent Change (as a percent) 0.20%  
Innovative Medicine | Immunology | International    
Sales by segment of business    
Sales to customers $ 1,794 1,664
Percent Change (as a percent) 7.90%  
Innovative Medicine | Immunology | REMICADE    
Sales by segment of business    
Sales to customers $ 434 487
Percent Change (as a percent) (10.90%)  
Innovative Medicine | Immunology | REMICADE | U.S.    
Sales by segment of business    
Sales to customers $ 266 276
Percent Change (as a percent) (3.90%)  
Innovative Medicine | Immunology | REMICADE | U.S. Exports    
Sales by segment of business    
Sales to customers $ 27 41
Percent Change (as a percent) (32.70%)  
Innovative Medicine | Immunology | REMICADE | International    
Sales by segment of business    
Sales to customers $ 141 170
Percent Change (as a percent) (17.20%)  
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA    
Sales by segment of business    
Sales to customers $ 554 537
Percent Change (as a percent) 3.00%  
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | U.S.    
Sales by segment of business    
Sales to customers $ 254 271
Percent Change (as a percent) (6.20%)  
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | International    
Sales by segment of business    
Sales to customers $ 299 266
Percent Change (as a percent) 12.40%  
Innovative Medicine | Immunology | STELARA    
Sales by segment of business    
Sales to customers $ 2,451 2,444
Percent Change (as a percent) 0.30%  
Innovative Medicine | Immunology | STELARA | U.S.    
Sales by segment of business    
Sales to customers $ 1,396 1,451
Percent Change (as a percent) (3.80%)  
Innovative Medicine | Immunology | STELARA | International    
Sales by segment of business    
Sales to customers $ 1,055 993
Percent Change (as a percent) 6.20%  
Innovative Medicine | Immunology | TREMFYA    
Sales by segment of business    
Sales to customers $ 808 640
Percent Change (as a percent) 26.30%  
Innovative Medicine | Immunology | TREMFYA | U.S.    
Sales by segment of business    
Sales to customers $ 509 406
Percent Change (as a percent) 25.40%  
Innovative Medicine | Immunology | TREMFYA | International    
Sales by segment of business    
Sales to customers $ 299 234
Percent Change (as a percent) 27.90%  
Innovative Medicine | Immunology | OTHER IMMUNOLOGY    
Sales by segment of business    
Sales to customers $ 0 3
Innovative Medicine | Immunology | OTHER IMMUNOLOGY | U.S.    
Sales by segment of business    
Sales to customers 0 3
Innovative Medicine | Immunology | OTHER IMMUNOLOGY | International    
Sales by segment of business    
Sales to customers $ 0 0
Percent Change (as a percent) 0.00%  
Innovative Medicine | Infectious Diseases    
Sales by segment of business    
Sales to customers $ 821 1,586
Percent Change (as a percent) (48.30%)  
Innovative Medicine | Infectious Diseases | U.S.    
Sales by segment of business    
Sales to customers $ 324 392
Percent Change (as a percent) (17.40%)  
Innovative Medicine | Infectious Diseases | International    
Sales by segment of business    
Sales to customers $ 497 1,193
Percent Change (as a percent) (58.40%)  
Innovative Medicine | Infectious Diseases | COVID-19    
Sales by segment of business    
Sales to customers $ 25 747
Percent Change (as a percent) (96.60%)  
Innovative Medicine | Infectious Diseases | COVID-19 | U.S.    
Sales by segment of business    
Sales to customers $ 0 $ 0
Percent Change (as a percent)   0.00%
Innovative Medicine | Infectious Diseases | COVID-19 | International    
Sales by segment of business    
Sales to customers $ 25 $ 747
Percent Change (as a percent) (96.60%)  
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine    
Sales by segment of business    
Sales to customers $ 323 280
Percent Change (as a percent) 15.70%  
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine | U.S.    
Sales by segment of business    
Sales to customers $ 8 9
Percent Change (as a percent) (10.90%)  
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine | International    
Sales by segment of business    
Sales to customers $ 315 271
Percent Change (as a percent) 16.60%  
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA    
Sales by segment of business    
Sales to customers $ 418 477
Percent Change (as a percent) (12.30%)  
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | U.S.    
Sales by segment of business    
Sales to customers $ 314 378
Percent Change (as a percent) (16.90%)  
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | International    
Sales by segment of business    
Sales to customers $ 104 99
Percent Change (as a percent) 5.50%  
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES(    
Sales by segment of business    
Sales to customers $ 53 82
Percent Change (as a percent) (35.10%)  
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES( | U.S.    
Sales by segment of business    
Sales to customers $ 2 5
Percent Change (as a percent) (68.80%)  
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES( | International    
Sales by segment of business    
Sales to customers $ 52 77
Percent Change (as a percent) (32.80%)  
Innovative Medicine | Neuroscience    
Sales by segment of business    
Sales to customers $ 1,803 1,804
Percent Change (as a percent) 0.00%  
Innovative Medicine | Neuroscience | U.S.    
Sales by segment of business    
Sales to customers $ 1,054 978
Percent Change (as a percent) 7.80%  
Innovative Medicine | Neuroscience | International    
Sales by segment of business    
Sales to customers $ 749 826
Percent Change (as a percent) (9.30%)  
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate    
Sales by segment of business    
Sales to customers $ 177 206
Percent Change (as a percent) (14.10%)  
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate | U.S.    
Sales by segment of business    
Sales to customers $ 41 70
Percent Change (as a percent) (41.20%)  
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate | International    
Sales by segment of business    
Sales to customers $ 136 136
Percent Change (as a percent) (0.10%)  
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA    
Sales by segment of business    
Sales to customers $ 1,056 1,044
Percent Change (as a percent) 1.20%  
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | U.S.    
Sales by segment of business    
Sales to customers $ 765 713
Percent Change (as a percent) 7.20%  
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | International    
Sales by segment of business    
Sales to customers $ 292 331
Percent Change (as a percent) (11.80%)  
Innovative Medicine | Neuroscience | SPRAVATO    
Sales by segment of business    
Sales to customers $ 225 131
Percent Change (as a percent) 72.20%  
Innovative Medicine | Neuroscience | SPRAVATO | U.S.    
Sales by segment of business    
Sales to customers $ 191 111
Percent Change (as a percent) 71.50%  
Innovative Medicine | Neuroscience | SPRAVATO | International    
Sales by segment of business    
Sales to customers $ 34 20
Percent Change (as a percent) 76.10%  
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE    
Sales by segment of business    
Sales to customers $ 345 423
Percent Change (as a percent) (18.50%)  
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | U.S.    
Sales by segment of business    
Sales to customers $ 58 84
Percent Change (as a percent) (31.10%)  
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | International    
Sales by segment of business    
Sales to customers $ 287 339
Percent Change (as a percent) (15.50%)  
Innovative Medicine | Oncology    
Sales by segment of business    
Sales to customers $ 4,814 4,112
Percent Change (as a percent) 17.10%  
Innovative Medicine | Oncology | U.S.    
Sales by segment of business    
Sales to customers $ 2,383 1,889
Percent Change (as a percent) 26.20%  
Innovative Medicine | Oncology | International    
Sales by segment of business    
Sales to customers $ 2,430 2,223
Percent Change (as a percent) 9.30%  
Innovative Medicine | Oncology | CARVYKTI    
Sales by segment of business    
Sales to customers $ 157 72
Innovative Medicine | Oncology | CARVYKTI | U.S.    
Sales by segment of business    
Sales to customers $ 140 70
Percent Change (as a percent) 99.80%  
Innovative Medicine | Oncology | CARVYKTI | International    
Sales by segment of business    
Sales to customers $ 16 2
Innovative Medicine | Oncology | DARZALEX    
Sales by segment of business    
Sales to customers $ 2,692 2,264
Percent Change (as a percent) 18.90%  
Innovative Medicine | Oncology | DARZALEX | U.S.    
Sales by segment of business    
Sales to customers $ 1,464 1,191
Percent Change (as a percent) 22.90%  
Innovative Medicine | Oncology | DARZALEX | International    
Sales by segment of business    
Sales to customers $ 1,228 1,072
Percent Change (as a percent) 14.50%  
Innovative Medicine | Oncology | ERLEADA    
Sales by segment of business    
Sales to customers $ 689 542
Percent Change (as a percent) 27.00%  
Innovative Medicine | Oncology | ERLEADA | U.S.    
Sales by segment of business    
Sales to customers $ 285 249
Percent Change (as a percent) 14.10%  
Innovative Medicine | Oncology | ERLEADA | International    
Sales by segment of business    
Sales to customers $ 404 293
Percent Change (as a percent) 38.00%  
Innovative Medicine | Oncology | IMBRUVICA    
Sales by segment of business    
Sales to customers $ 784 827
Percent Change (as a percent) (5.20%)  
Innovative Medicine | Oncology | IMBRUVICA | U.S.    
Sales by segment of business    
Sales to customers $ 265 270
Percent Change (as a percent) (1.50%)  
Innovative Medicine | Oncology | IMBRUVICA | International    
Sales by segment of business    
Sales to customers $ 518 557
Percent Change (as a percent) (7.00%)  
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate    
Sales by segment of business    
Sales to customers $ 181 245
Percent Change (as a percent) (25.90%)  
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate | U.S.    
Sales by segment of business    
Sales to customers $ 9 16
Percent Change (as a percent) (41.30%)  
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate | International    
Sales by segment of business    
Sales to customers $ 172 229
Percent Change (as a percent) (24.80%)  
Innovative Medicine | Oncology | OTHER ONCOLOGY    
Sales by segment of business    
Sales to customers $ 178 99
Percent Change (as a percent) 80.20%  
Innovative Medicine | Oncology | OTHER ONCOLOGY | U.S.    
Sales by segment of business    
Sales to customers $ 119 35
Innovative Medicine | Oncology | OTHER ONCOLOGY | International    
Sales by segment of business    
Sales to customers $ 60 64
Percent Change (as a percent) (6.10%)  
Innovative Medicine | Oncology | Tecvayli    
Sales by segment of business    
Sales to customers $ 133 63
Innovative Medicine | Oncology | Tecvayli | U.S.    
Sales by segment of business    
Sales to customers $ 101 57
Percent Change (as a percent) 76.70%  
Innovative Medicine | Oncology | Tecvayli | International    
Sales by segment of business    
Sales to customers $ 33 6
Innovative Medicine | Pulmonary Hypertension    
Sales by segment of business    
Sales to customers $ 1,049 872
Percent Change (as a percent) 20.20%  
Innovative Medicine | Pulmonary Hypertension | U.S.    
Sales by segment of business    
Sales to customers $ 766 600
Percent Change (as a percent) 27.50%  
Innovative Medicine | Pulmonary Hypertension | International    
Sales by segment of business    
Sales to customers $ 283 272
Percent Change (as a percent) 4.10%  
Innovative Medicine | Pulmonary Hypertension | OPSUMIT    
Sales by segment of business    
Sales to customers $ 524 440
Percent Change (as a percent) 19.10%  
Innovative Medicine | Pulmonary Hypertension | OPSUMIT | U.S.    
Sales by segment of business    
Sales to customers $ 356 273
Percent Change (as a percent) 30.40%  
Innovative Medicine | Pulmonary Hypertension | OPSUMIT | International    
Sales by segment of business    
Sales to customers $ 169 167
Percent Change (as a percent) 0.80%  
Innovative Medicine | Pulmonary Hypertension | UPTRAVI    
Sales by segment of business    
Sales to customers $ 468 362
Percent Change (as a percent) 29.20%  
Innovative Medicine | Pulmonary Hypertension | UPTRAVI | U.S.    
Sales by segment of business    
Sales to customers $ 392 304
Percent Change (as a percent) 29.00%  
Innovative Medicine | Pulmonary Hypertension | UPTRAVI | International    
Sales by segment of business    
Sales to customers $ 76 58
Percent Change (as a percent) 30.70%  
Innovative Medicine | Pulmonary Hypertension | Other    
Sales by segment of business    
Sales to customers $ 56 70
Percent Change (as a percent) (19.50%)  
Innovative Medicine | Pulmonary Hypertension | Other | U.S.    
Sales by segment of business    
Sales to customers $ 18 23
Percent Change (as a percent) (24.60%)  
Innovative Medicine | Pulmonary Hypertension | Other | International    
Sales by segment of business    
Sales to customers $ 39 47
Percent Change (as a percent) (16.90%)  
Innovative Medicine | Cardiovascular / Metabolism / Other    
Sales by segment of business    
Sales to customers $ 829 927
Percent Change (as a percent) (10.60%)  
Innovative Medicine | Cardiovascular / Metabolism / Other | U.S.    
Sales by segment of business    
Sales to customers $ 631 715
Percent Change (as a percent) (11.70%)  
Innovative Medicine | Cardiovascular / Metabolism / Other | International    
Sales by segment of business    
Sales to customers $ 197 212
Percent Change (as a percent) (7.00%)  
Innovative Medicine | Cardiovascular / Metabolism / Other | Other    
Sales by segment of business    
Sales to customers $ 311 349
Percent Change (as a percent) (11.00%)  
Innovative Medicine | Cardiovascular / Metabolism / Other | Other | U.S.    
Sales by segment of business    
Sales to customers $ 114 137
Percent Change (as a percent) (17.10%)  
Innovative Medicine | Cardiovascular / Metabolism / Other | Other | International    
Sales by segment of business    
Sales to customers $ 197 212
Percent Change (as a percent) (7.00%)  
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO    
Sales by segment of business    
Sales to customers $ 518 578
Percent Change (as a percent) (10.40%)  
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | U.S.    
Sales by segment of business    
Sales to customers $ 518 578
Percent Change (as a percent) (10.40%)  
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | International    
Sales by segment of business    
Sales to customers $ 0 $ 0
Percent Change (as a percent) 0.00%